Patent · US Active

Ophthalmic compositions comprising tafluprost for the treatment of glaucoma

US12226422B2 · kind B2 · utility

2Cited by

99References

19Claims

0Family size

Assignee

NOVALIQ GMBH · DE

Inventors

Frank LÖSCHER · Schriesheim, DE
Diana STREHL · Heidelberg, DE
Kirsten EICKHOFF · Aschaffenburg, DE

Key dates

Filing date	Apr 24, 2019
Grant date	Feb 18, 2025
Priority date	—
Expiry date	Dec 4, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein the composition comprises tafluprost and a semifluorinated alkane.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.